$CBRS

Cerebras Systems Inc.

Insider trades
13
17
31

No SEC Form 4 filings for $CBRS in the last 30 days.

See all $CBRS insider activity →
Med

Stock market today: Dow, S&P 500, Nasdaq trending higher on rate hike bets, earnings

US stock index futures rose on Thursday as investors weighed upcoming inflation data and earnings. Dow Jones futures gained 0.3%, S&P 500 futures 0.2%, and Nasdaq-100 futures 0.1%. Cisco (CSCO) and Cerebras (CBRS) reported results, while Applied Materials (AMAT) is due. Producer Price Index inflation came in below expectations, supporting rate-hike bets.

Why Cerebras Systems Stock Just Sank

Cerebras Systems (CBRS) shares fell about 11.9% after its Q2 report missed Wall Street sales and earnings expectations. The company posted a net loss of $2.98 per share on revenue of $180.11 million, below forecasts. It nonetheless raised full-year non-GAAP core sales to $880 million to $890 million and margin targets.

Anthropic Expects Mind-Blowing $200 Billion Revenue in 2028 as IPO Looms

Reuters reports Anthropic is preparing an October IPO, with bankers valuing the deal using a 2028 revenue forecast of about $190B to $200B, implying a roughly $2T valuation. Company figures cite revenue rising from about $9B run rate at end-2025 to over $47B by May, with Q2 2026 revenue projected at least $10.9B and first quarterly operating profit of $559M.

CBRS sentiment & insider activity

Over the past 7 days, alphai's AI scored 61 news stories mentioning CBRS (Cerebras Systems Inc.). Coverage has skewed bearish: 13 bullish, 17 neutral, and 31 bearish.

Recent CBRS coverage spans macro economy, earnings and market movers.

What's driving CBRS

  • Despite an earnings beat, the selloff indicates investors may be discounting forward demand, profitability, or guidance quality.

    aol.com · Aug 16, 2026

  • The Q2 miss likely drives near-term downside risk, but raised full-year targets may cushion the selloff and shift focus to execution.

    aol.com · Aug 15, 2026

  • CBRS is used as a historical analog for how distant-future IPO pricing can unwind after quarterly results.

    247wallst.com · Aug 15, 2026

  • Strong growth and raised guidance tied to WSE-3 commercial traction and OpenAI partnership, supporting bullish positioning but with execution and demand-risk.

    livetradingnews.com · Aug 15, 2026

  • Negative earnings reaction suggests elevated downside risk and potential de-risking in AI infrastructure names.

    yahoo.com · Aug 15, 2026

alphai scores every news story that mentions CBRS with an AI model for sentiment and relevance, and aggregates insider trades from Cerebras Systems Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $CBRS

Score
$CBRSMedAI 8/10

Why Cerebras Systems Stock Just Sank

Cerebras Systems (CBRS) shares fell about 11.9% after its Q2 report missed Wall Street sales and earnings expectations. The company posted a net loss of $2.98 per share on revenue of $180.11 million, below forecasts. It nonetheless raised full-year non-GAAP core sales to $880 million to $890 million and margin targets.

$CBRSLow

Anthropic Expects Mind-Blowing $200 Billion Revenue in 2028 as IPO Looms

Reuters reports Anthropic is preparing an October IPO, with bankers valuing the deal using a 2028 revenue forecast of about $190B to $200B, implying a roughly $2T valuation. Company figures cite revenue rising from about $9B run rate at end-2025 to over $47B by May, with Q2 2026 revenue projected at least $10.9B and first quarterly operating profit of $559M.

Cerebras WSE-3: The Wafer-Scale Engine Behind Fast AI Inference

Cerebras Systems reported Q2 2026 core total revenue of $209.9 million, up 103% year over year, and record core cloud and other services revenue of $127.7 million, up 287%. Data-center capacity under contract exceeded 600 MW. The company raised its 2026 core revenue outlook to $880 million to $890 million and said OpenAI selected it as a GPT-5.6 Sol launch partner.

$AMZNMed

Stocks Rally on the Favorable US PPI Report

Stocks rose after a favorable US PPI report. An Iranian military spokesperson said Iran controls Strait of Hormuz passage, responding to President Trump’s “total control” claim. Bloomberg Intelligence cited Q2 S&P 500 earnings growth near 32% and 85% of reported companies beating estimates. Rates markets shifted toward fewer hikes; 10-year yields fell. Notable movers included TSLA, META, CSCO, and MU.

$CBRSMed

AI Demand Is Booming. So Why Are CBRS and CSCO Sinking?

Cerebras Systems (CBRS) and Cisco (CSCO) fell Thursday despite strong AI infrastructure results. Cerebras reported record $209.9M core revenue (+103% YoY), $25.4B remaining performance obligations, and raised guidance. Cisco posted $17.25B revenue (+18%) and $4B hyperscaler AI orders in Q4, with $7.5B hyperscaler AI revenue expected in FY2027. Shares dropped as investors focused on acceleration, margins, and execution.

$METAMed

Stocks See Support from Favorable PPI Report

The article cites an Iranian military spokesperson saying Iran authorizes and supervises safe passage through the Strait of Hormuz, responding to President Trump’s claim of US “total control.” It also reports S&P 500 Q2 earnings growth expectations near 32% versus 23% and 85% of 446 companies beating estimates, plus Treasury moves after a favorable PPI report. It lists several stock movers including META, MSFT, AMD, SOXX, CSCO, and CRM.

$CBRSMedAI 8/10

Cerebras Sees Neo-Clouds Breaking Away From NVIDIA Dependence — Calls 2027 Opportunity ‘Large’

Cerebras Systems (CBRS) shares fell in premarket after mixed Q2 results. Adjusted loss was 4.5 cents per share versus a 17-cent estimate; revenue was $180.11M vs $194.20M consensus. Core revenue hit $209.9M, up 103% YoY, with core gross margin 40.6%. The company raised FY2026 outlook and expects 2027 growth tied to neo-cloud demand and reduced NVIDIA dependence.

Related tickers